Evaluating Population Impact of HCV DAA Treatment as Prevention to People Who Inject Drugs (EPI-TaP) (joint with University of Bristol)

StatusActive
Effective start/end date1/02/1831/01/23

Funding

  • (RP-PG-0616-20008): £716,079.00